The High Court in Pretoria, has refused iDexis (Pty) Ltd, trading as Sentra Pharmacy, permission to appeal an interim order preventing it from manufacturing, supplying and marketing certain compounded medicines containing semaglutide.
iDexis, a compounding pharmacy based in Silverton, Pretoria, specialises in compounded medicines for healthcare providers.
The pharmacy is challenging an order obtained by pharmaceutical giant Novo Nordisk, after c…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.